ChipCare Blog ChipCare Retains Biotech Alliances International to Lead Series B Capital Raise

ChipCare, a Toronto-based start-up diagnostic company, announced today that San Francisco-based life sciences investment bank Biotech Alliances International will serve as the lead investment banker for its $18.8 million Series B capital raise, $2.8 million of which has already been...The post ChipCare Retains Biotech Alliances International to Lead Series B Capital Raise appeared first on Chipcare Corporation.